Viewing Study NCT02052661


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-04-22 @ 4:43 AM
Study NCT ID: NCT02052661
Status: COMPLETED
Last Update Posted: 2018-06-06
First Post: 2014-01-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 106793
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators